These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12614671)

  • 1. Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease.
    Sergeant N; Wattez A; Galván-valencia M; Ghestem A; David JP; Lemoine J; Sautiére PE; Dachary J; Mazat JP; Michalski JC; Velours J; Mena-López R; Delacourte A
    Neuroscience; 2003; 117(2):293-303. PubMed ID: 12614671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer's disease pathology.
    Terni B; Boada J; Portero-Otin M; Pamplona R; Ferrer I
    Brain Pathol; 2010 Jan; 20(1):222-33. PubMed ID: 19298596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
    Leroy K; Yilmaz Z; Brion JP
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP synthase and Alzheimer's disease: putting a spin on the mitochondrial hypothesis.
    Ebanks B; Ingram TL; Chakrabarti L
    Aging (Albany NY); 2020 Aug; 12(16):16647-16662. PubMed ID: 32853175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
    Armstrong RA
    Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
    Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
    Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
    Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
    FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.
    Bonkale WL; Cowburn RF; Ohm TG; Bogdanovic N; Fastbom J
    Brain Res; 1999 Feb; 818(2):383-96. PubMed ID: 10082824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
    Zhu X; Raina AK; Rottkamp CA; Aliev G; Perry G; Boux H; Smith MA
    J Neurochem; 2001 Jan; 76(2):435-41. PubMed ID: 11208906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer's Disease.
    Patro S; Ratna S; Yamamoto HA; Ebenezer AT; Ferguson DS; Kaur A; McIntyre BC; Snow R; Solesio ME
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing novel 1-aza-9-oxafluorenes as selective GSK-3beta inhibitors.
    Voigt B; Krug M; Schächtele C; Totzke F; Hilgeroth A
    ChemMedChem; 2008 Jan; 3(1):120-6. PubMed ID: 18000938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.
    Brici D; Götz J; Nisbet RM
    J Alzheimers Dis; 2018; 61(3):899-905. PubMed ID: 29332046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions.
    Kannanayakal TJ; Tao H; Vandre DD; Kuret J
    Acta Neuropathol; 2006 May; 111(5):413-21. PubMed ID: 16557393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
    Luan K; Rosales JL; Lee KY
    Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease.
    Perry G; Richey PL; Siedlak SL; Smith MA; Mulvihill P; DeWitt DA; Barnett J; Greenberg BD; Kalaria RN
    Am J Pathol; 1993 Dec; 143(6):1586-93. PubMed ID: 7504885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
    Imahori K; Uchida T
    J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3 alpha and 3 beta do not colocalize with neurofibrillary tangles.
    Harr SD; Hollister RD; Hyman BT
    Neurobiol Aging; 1996; 17(3):343-8. PubMed ID: 8725894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.
    Smith MA; Kutty RK; Richey PL; Yan SD; Stern D; Chader GJ; Wiggert B; Petersen RB; Perry G
    Am J Pathol; 1994 Jul; 145(1):42-7. PubMed ID: 8030754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.